Fortitude Family Office’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
Other funds holding TMCI
AC
GS
VCM
CBU
Fortitude Family Office's TMCI Position: Q1 2026 in Review
Fortitude Family Office increased its Treace Medical Concepts (TMCI) stake by 11% in Q1 2026, buying an estimated $70 and bringing the position to 342 shares worth $458. The position accounts for ﹤0.01% of the portfolio, ranked #1762.
Fortitude Family Office first reported a position in TMCI in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.15K in Q2 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.
- Fortitude Family Office held 342 shares of Treace Medical Concepts worth $458 as of Q1 2026.
- Fortitude Family Office bought 35 Treace Medical Concepts shares in Q1 2026, an estimated $70.
- Treace Medical Concepts made up ﹤0.01% of Fortitude Family Office's portfolio in Q1 2026, its #1762 holding.
- Fortitude Family Office first reported a position in Treace Medical Concepts in Q4 2024 and has held it in 6 quarters since.
- Fortitude Family Office's Treace Medical Concepts position peaked at $5.15K in Q2 2025.
- 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.
Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.